IONS
USDIonis Pharmaceuticals Inc. Common Stock
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$73.790
Haut
$75.000
Bas
$72.360
Volume
0.79M
Fondamentaux de l'Entreprise
Capitalisation Boursière
11.9B
Industrie
Biotechnologie
Pays
United States
Statistiques de Trading
Volume Moyen
2.47M
Bourse
NMS
Devise
USD
Intervalle sur 52 Semaines
Actualités Connexes
HC Wainwright & Co. Maintains Buy on Ionis Pharmaceuticals, Raises Price Target to $110
HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Ionis Pharmaceuticals with a Buy and raises the price target from $100 to $110.
Piper Sandler Maintains Overweight on Ionis Pharmaceuticals, Raises Price Target to $77
Piper Sandler analyst Allison Bratzel maintains Ionis Pharmaceuticals with a Overweight and raises the price target from $70 to $77.
TD Cowen Maintains Buy on Ionis Pharmaceuticals, Raises Price Target to $99
TD Cowen analyst Yaron Werber maintains Ionis Pharmaceuticals with a Buy and raises the price target from $59 to $99.
Morgan Stanley Maintains Overweight on Ionis Pharmaceuticals, Raises Price Target to $94
Morgan Stanley analyst Michael Ulz maintains Ionis Pharmaceuticals with a Overweight and raises the price target from $90 to $94.
HC Wainwright & Co. Maintains Buy on Ionis Pharmaceuticals, Raises Price Target to $100
HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Ionis Pharmaceuticals with a Buy and raises the price target from $95 to $100.
Barclays Maintains Overweight on Ionis Pharmaceuticals, Raises Price Target to $95
Barclays analyst Gena Wang maintains Ionis Pharmaceuticals with a Overweight and raises the price target from $80 to $95.
RBC Capital Maintains Outperform on Ionis Pharmaceuticals, Raises Price Target to $82
RBC Capital analyst Luca Issi maintains Ionis Pharmaceuticals with a Outperform and raises the price target from $80 to $82.
Actions Connexes
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.